Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

Document and Entity Information - shares
3 Months Ended
Mar. 31, 2022
Jul. 07, 2022
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Mar. 31, 2022  
Entity File Number 001-36672  
Entity Registrant Name KIORA PHARMACEUTICALS, INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 98-0443284  
Entity Address, Address Line One 1371 East 2100 South  
Entity Address, Address Line Two Suite 200  
Entity Address, City or Town Salt Lake City  
Entity Address, State or Province UT  
Entity Address, Postal Zip Code 84105  
City Area Code 781  
Local Phone Number 788-8869  
Title of 12(b) Security Common Stock, $0.01 par value  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Trading Symbol KPRX  
Entity Common Stock, Shares Outstanding   13,067,426
Entity Central Index Key 0001372514  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q1  
Amendment Flag false